Pharmaceutical Chemistry Journal

, Volume 10, Issue 7, pp 849–856 | Cite as

Neurochemical aspects of the search for modern psychotropic drugs and the mechanism of their action

  • M. D. Mashkovskii
Molecular-Biological Problems in the Search for, Production of, and Mechanism of Action of Drugs
Received:

Keywords

Organic Chemistry Psychotropic Drug Neurochemical Aspect 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literature cited

  1. 1.
    I. P. Pavlov. Complete Collected Works [in Russian], Moscow-Leningrad, Vol. 3, Part 2 (1951), pp. 294–314.Google Scholar
  2. 2.
    O. Benkert and H. Hippius, Arzneim. Forsch.,25, 1195 (1975).Google Scholar
  3. 3.
    G. Barger and H. Dale, J. Physiol. (Lond.),41, 19 (1910).Google Scholar
  4. 4.
    C. Best, H. Dale, H. Dudley, et al., J. Physiol. (Lond.),62, 397 (1927).Google Scholar
  5. 5.
    D. Bovet and A. Staub, C. R. Soc. Biol.,124, 547 (1937).Google Scholar
  6. 6.
    B. Halpern and R. Ducrot, C. R. Soc. Biol.,140, 361 (1946).Google Scholar
  7. 7.
    H. Laborit and P. Huguenard, Presse Med.,59, 1329 (1951).Google Scholar
  8. 8.
    S. V. Anichkov, The Selective Action of Mediator Substances [in Russian], Leningrad (1974).Google Scholar
  9. 9.
    M. D. Mashkovskii, in: Current Problems of Neuropathology and Psychiatry (ed. by N. K. Bogolepov and I. Temkov) [in Russian], Moscow (1974), pp. 263–281.Google Scholar
  10. 10.
    M. Vogt, Pharmacol. Rev.,11, 483 (1959).Google Scholar
  11. 11.
    B. Twarog and J. Page, Am. J. Physiol.,175, 157 (1953).Google Scholar
  12. 12.
    M. Rinkel and G. Denber, The Biochemistry of Psychoses [in Russian].Google Scholar
  13. 13.
    J. Gaddum and K. Hameed, Brit. J. Pharmacol.,9, 240 (1954).Google Scholar
  14. 14.
    D. Woolley and E. Shaw, Science,119, 587 (1954).Google Scholar
  15. 15.
    M. D. Mashkovskii, A. I. Polezhaeva, G. Ya. Avrutskii, et al., Zh. Nevropatol. Psikhiatr., No. 8, 1234 (1969).Google Scholar
  16. 16.
    M. D. Mashkovskii and N. I. Andreeva, Zh. Nevropatol. Psikhiatr., No. 3, 430 (1975).Google Scholar
  17. 17.
    G. Ya. Avrustkii, V. V. Gromova, and S. G. Zaitsev, Zh. Nevropatol. Psikhiatr., No. 5, 734 (1975).Google Scholar
  18. 18.
    Investigations in the Field of Psychopharmacology (WHO Series of Technical Lectures, No. 371) [Russian translation], Moscow (1969).Google Scholar
  19. 19.
    M. D. Maskovskii, R. A. Al'tshuler, G. Ya. Avrutskii, et al., Zh. Nevropatol. Psikhiatr., No. 11, 1704 (1971).Google Scholar
  20. 20.
    M. Klein and A. Sobor, Zh. Nevropatol. Psikhiatr., No. 2, 275 (1975).Google Scholar
  21. 21.
    Z. Linka, Zh. Nevropatol. Psikhiatr., No. 2, 278 (1975).Google Scholar
  22. 22.
    M. Paasonen and M. Vogt, J. Physiol. (Lond.),131, 617 (1956).Google Scholar
  23. 23.
    M. Holzbauer and M. Vogt, J. Neurochem.,1, 8 (1956).Google Scholar
  24. 24.
    S. Spector, D. Prockop, P. Shore, et al., Science,127, 704 (1958).Google Scholar
  25. 25.
    E. Zeller, J. Barsky, J. Fouts, et al., Experientia,8, 349 (1952).Google Scholar
  26. 26.
    J. Glowinski and J. Axelrod, Pharmacol. Rev.,18, 715 (1966).Google Scholar
  27. 27.
    A. Carlsson and M. Lindqvist, Acta Pharmacol. (Copenhagen),20, 140 (1963).Google Scholar
  28. 28.
    L. Iversen, Science,188, 1084 (1975).Google Scholar
  29. 29.
    P. Seeman and T. Lee, Science,188, 1217 (1975).Google Scholar
  30. 30.
    S. Shyder, S. Banerjee, H. Yamamura, et al., Science,184, 1243 (1974).Google Scholar
  31. 31.
    Dzh. Devis, Vestn. Akad. Med. Nauk SSSR, No. 9, 55 (1975).Google Scholar
  32. 32.
    L. Ya. Zin'kovskaya and I. V. Komissarov, Zh. Nevropatol. Psikhiatr., No. 3, 426 (1975).Google Scholar
  33. 33.
    M. D. Mashkovskii, V. Z. Gorkin, N. I. Andreeva, et al., Farmakol. Toksikol., No. 5, 531 (1975).Google Scholar
  34. 34.
    R. A. Al'tshuler, L. F. Roshchina, and M. D. Mashkovskii, Farmakol. Toksikol., No. 1, 9 (1976).Google Scholar
  35. 35.
    I. Schildkraut, Int. J. Psychiat.,4, No. 3, 203 (1967).Google Scholar
  36. 36.
    I. Schildkraut, Pharmakopsychiat. Neuro-Psychopharmakol.,7, 98 (1974).Google Scholar
  37. 37.
    I. Lapin and G. Oxenkrug, Lancet,1, 132 (1969).Google Scholar
  38. 38.
    D. Curtis, A. Duggan, D. Flix, et al., Nature,226, 1222 (1970).Google Scholar
  39. 39.
    I. A. Sytinskii, Zh. Vses. Khim. O-va,18, 182 (1973).Google Scholar
  40. 40.
    N. I. Maisov, N. S. Tolmacheva, and K. S. 'Raevskii, Farmakol. Toksikol.,38, No. 5, 537 (1975).Google Scholar
  41. 41.
    K. Fuxe, T. Hökfelt, A. Ljungdahl, et al., Med. Biol.,53, 177 (1975).Google Scholar
  42. 42.
    A. Stegink, Arzneim. Forsch.,21, 975 (1972).Google Scholar

Copyright information

© Plenum Publishing Corporation 1977

Authors and Affiliations

  • M. D. Mashkovskii
    • 1
  1. 1.S. Ordzhonikidze All-Union Scientific-Research Institute of Pharmaceutical ChemistryMoscow

Personalised recommendations